Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)

NCT02140463 · clinicaltrials.gov ↗
COMPLETED
Status
229
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Samsung Medical Center